Related Experiment Video
Updated: May 14, 2026

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome
Yang Luo1, Cheng Wang, Xi Chen
1Department of Clinical Laboratory, Jinling Hospital, School of Life Sciences, Nanjing University, Nanjing, China.
Background:
MicroRNAs (miRNAs) are present in body fluids and may have the potential to serve as disease biomarkers. This study explored the clinical value of miRNAs in serum and urine as biomarkers for idiopathic childhood nephrotic syndrome (NS).
Methods:
We obtained serum samples from 159 NS children (24 steroid resistant and 135 steroid sensitive), 109 age/sex-matched healthy controls and 44 children with other kidney diseases. Serum miRNAs were analyzed with the TaqMan Low Density Array and then validated with a quantitative reverse-transcription PCR assay with 126 individual samples. Moreover, we collected paired serum samples from 50 patients before and after treatment to determine the value of these miRNAs for condition assessment. In addition, urine samples from these patients were examined for candidate miRNAs.
Results:
The concentrations of serum miR-30a-5p, miR-151-3p, miR-150, miR-191, and miR-19b were highly increased in NS children compared with controls (P < 0.0001). The urinary miR-30a-5p concentration was also increased in NS (P = 0.001). The area under the ROC curve and the odds ratio for the combined 5 serum miRNAs were 0.90 (95% CI, 0.86-0.94; P < 0.0001) and 40.7 (95% CI, 6.06-103; P < 0.0001), respectively. Moreover, the concentrations of the 5 serum miRNAs and urinary miR-30a-5p markedly declined with the clinical improvement of the patients.
Conclusions:
We determined that 5 distinct serum miRNAs and urinary miR-30a-5p were increased in NS children. These circulating or urinary miRNAs may represent potential diagnostic and prognostic biomarkers for idiopathic pediatric NS.
Insights
Five specific serum microRNAs (miRNAs) and urinary miR-30a-5p show increased levels in children with nephrotic syndrome (NS). These biomarkers may aid in diagnosing and assessing pediatric NS.
Area of Science:
- Biochemistry
- Molecular Biology
- Pediatric Nephrology
Background:
- MicroRNAs (miRNAs) in body fluids show potential as disease biomarkers.
- Idiopathic childhood nephrotic syndrome (NS) diagnosis can be challenging.
- Identifying reliable biomarkers for pediatric NS is crucial for timely intervention.
Purpose of the Study:
- To investigate the clinical utility of serum and urine miRNAs as biomarkers for idiopathic childhood nephrotic syndrome (NS).
- To identify specific miRNA profiles associated with NS in pediatric patients.
- To assess the potential of these miRNAs for disease diagnosis and monitoring.
Main Methods:
- Serum samples analyzed from 159 NS children, 109 healthy controls, and 44 with other kidney diseases.
- miRNA expression profiling using TaqMan Low Density Array and quantitative reverse-transcription PCR.
- Paired serum and urine samples collected pre- and post-treatment for condition assessment.
Main Results:
- Five serum miRNAs (miR-30a-5p, miR-151-3p, miR-150, miR-191, miR-19b) and urinary miR-30a-5p were significantly elevated in NS children.
- Combined serum miRNAs demonstrated high diagnostic accuracy (AUC 0.90).
- Concentrations of these miRNAs decreased with clinical improvement, indicating prognostic value.
Conclusions:
- Elevated serum and urinary miRNAs (miR-30a-5p, miR-151-3p, miR-150, miR-191, miR-19b) are associated with pediatric NS.
- These miRNAs show promise as non-invasive diagnostic and prognostic biomarkers for idiopathic childhood NS.
- Further validation could lead to improved clinical management of pediatric NS.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Diabetic Nephropathy
Nephrons
Chronic Kidney Disease II: Clinical Manifestations

